Conference Coverage
Videos
NewsNetwork
OncLive® TV
Peer Exchange
Insights
Attend An Event
State of the Science Summit
Regional Seminar Series
PER Conferences

OS by PS in Metastatic Pancreatic Cancer Treatment- Data From an Exploratory Subgroup Analysis

SPECIALTY TOPICS
CURRENTLY VIEWING
All Specialties
Breast Cancer
Multiple Myeloma
Lung Cancer
Immuno-Oncology News
Gynecologic Oncology
Gastrointestinal Cancer
Colorectal Cancer
Prostate Cancer
Neoadjuvant HER2+
Brain Cancer
More >>

Ovarian Cancer Videos

Dr. Eskander on Need for Biomarkers in Ovarian Cancer
Dr. Eskander on Need for Biomarkers in Ovarian Cancer
Ramez N. Eskander, MD, assistant clinical professor, Department of Reproductive Medicine, University of California, San Diego Moores Cancer Center, discusses the need for more effective biomarkers in the treatment of patients with ovarian cancer.
Onclive TV   >   
Dr. Karam on the Use of Laparoscopy in Advanced Ovarian Cancer
Dr. Karam on the Use of Laparoscopy in Advanced Ovarian Cancer
Amer Karam, MD, associate clinical professor of Gynecologic Oncology at Stanford Hospital and director of Robotic Surgery and Outreach in the Division of Gynecologic Oncology at Stanford Medicine, discusses the use of laparoscopy in advanced ovarian cancer.
Onclive TV   >   
Dr. Grisham on Frontline Treatment for Low-Grade Serous Ovarian Cancer
Dr. Grisham on Frontline Treatment for Low-Grade Serous Ovarian Cancer
Rachel N. Grisham, medical oncologist, Memorial Sloan Kettering Cancer Center, discusses frontline treatment options for patients with low-grade serous ovarian cancer.
Onclive TV   >   
Dr. Eskander on Combination Approaches With Immunotherapy in Ovarian Cancer
Dr. Eskander on Combination Approaches With Immunotherapy in Ovarian Cancer
Ramez N. Eskander, MD, assistant clinical professor, Department of Reproductive Medicine, University of California, San Diego Moores Cancer Center, discusses combination approaches with immunotherapy in ovarian cancer.
Onclive TV   >   
Dr. English on an Investigational Antibody-Drug Conjugate in Ovarian Cancer
Dr. English on an Investigational Antibody-Drug Conjugate in Ovarian Cancer
Diana P. English, MD, a gynecologic oncologist at Stanford Hospital and Clinics, discusses an investigational antibody-drug conjugate (ADC) in ovarian cancer.
Onclive TV   >   
Dr. Horowitz on Frontline Strategies in Newly Diagnosed Ovarian Cancer
Dr. Horowitz on Frontline Strategies in Newly Diagnosed Ovarian Cancer
Neil Horowitz, MD, director of Clinical Research in Gynecologic Oncology, associate professor of Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School, Dana-Farber Cancer Institute, discusses frontline strategies in the treatment of patients with newly diagnosed advanced ovarian cancer.
Onclive TV   >   
Dr. Coleman on Advances Made in Ovarian Cancer Treatment
Dr. Coleman on Advances Made in Ovarian Cancer Treatment
Robert L. Coleman, MD, FACOG, FACS, professor, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, discusses advances made in the treatment of ovarian cancer.
Conference Coverage   >   2019 SGO Winter Meeting
Dr. Kurnit on Adjuvant Chemotherapy Regimens in Mucinous Ovarian Cancer
Dr. Kurnit on Adjuvant Chemotherapy Regimens in Mucinous Ovarian Cancer
Katherine Kurnit, MD, OBGYN oncology fellow at the University of Texas MD Anderson Cancer Center, compares the benefit of gastrointestinal-based versus gynecologic-based adjuvant chemotherapy regimens in patients with mucinous ovarian cancer.
Conference Coverage   >   2019 SGO Winter Meeting
Dr. Westin on Advances Made With PARP Inhibitors in Ovarian Cancer
Dr. Westin on Advances Made With PARP Inhibitors in Ovarian Cancer
Shannon N. Westin, MD, MPH, associate professor, The University of Texas MD Anderson Cancer Center, discusses advances made with PARP inhibitors in the ovarian cancer treatment paradigm.
Conference Coverage   >   2019 SGO Winter Meeting
Dr. Konstantinopoulos on the Phase III Results of the JAVELIN 200 Trial in Ovarian Cancer
Dr. Konstantinopoulos on the Phase III Results of the JAVELIN 200 Trial in Ovarian Cancer
Panagiotis A. Konstantinopoulos, MD, director, Translational Research, Gynecologic Oncology, Dana-Farber Cancer Institute, associate professor of medicine, Harvard Medical School, discusses the disappointing results of the JAVELIN 200 trial in ovarian cancer.
Onclive TV   >   
Next Page >>
Publication Bottom Border
Border Publication
 
x